Cogent Biosciences, Inc. Investment Income, Interest
Cogent Biosciences, Inc. (COGT) reported Investment Income, Interest of $7.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-10
- Cogent Biosciences, Inc. investment income, interest for the quarter ending 2026-06-30 was $7.46M, a 214.41% increase year-over-year.
- Cogent Biosciences, Inc. investment income, interest for the quarter ending 2026-03-31 was $7.61M, a 157.72% increase year-over-year.
- Cogent Biosciences, Inc. investment income, interest for the quarter ending 2025-12-31 was $5.48M, a 41.93% increase year-over-year.
- Cogent Biosciences, Inc. investment income, interest for the quarter ending 2025-09-30 was $3.89M, a 18.66% decline year-over-year.
- Cogent Biosciences, Inc. investment income, interest for fiscal 2025 was $14.69M, a 18.79% decline from fiscal 2024.
- Cogent Biosciences, Inc. investment income, interest for fiscal 2024 was $18.09M, a 38.32% increase from fiscal 2023.
- Cogent Biosciences, Inc. investment income, interest for fiscal 2023 was $13.08M, a 227.83% increase from fiscal 2022.
- Cogent Biosciences, Inc. investment income, interest for fiscal 2022 was $3.99M, a 754.18% increase from fiscal 2021.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $7.46M 10-Q · filed 2026-08-10 | $15.07M 10-Q · filed 2026-08-10 | $20.55M derived: sum of 3 quarters · filed 2026-08-10 | $24.43M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $7.61M 10-Q · filed 2026-05-05 | $13.09M derived: sum of 2 quarters · filed 2026-05-05 | $16.97M derived: sum of 3 quarters · filed 2026-05-05 | $19.34M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $5.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $9.36M derived: sum of 2 quarters · filed 2026-02-17 | $11.74M derived: sum of 3 quarters · filed 2026-08-10 | $14.69M 10-K · filed 2026-02-17 |
| 2025-09-30 | $3.89M 10-Q · filed 2025-11-07 | $6.26M derived: sum of 2 quarters · filed 2026-08-10 | $9.21M 10-Q · filed 2025-11-07 | $13.07M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $2.37M 10-Q · filed 2026-08-10 | $5.33M 10-Q · filed 2026-08-10 | $9.18M derived: sum of 3 quarters · filed 2026-08-10 | $13.96M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.95M 10-Q · filed 2026-05-05 | $6.81M derived: sum of 2 quarters · filed 2026-05-05 | $11.59M derived: sum of 3 quarters · filed 2026-05-05 | $16.98M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $3.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $8.64M derived: sum of 2 quarters · filed 2026-02-17 | $14.03M derived: sum of 3 quarters · filed 2026-02-17 | $18.09M 10-K · filed 2026-02-17 |
| 2024-09-30 | $4.78M 10-Q · filed 2025-11-07 | $10.17M derived: sum of 2 quarters · filed 2025-11-07 | $14.23M 10-Q · filed 2025-11-07 | $18.10M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-06-30 | $5.39M 10-Q · filed 2025-08-05 | $9.45M 10-Q · filed 2025-08-05 | $13.32M derived: sum of 3 quarters · filed 2026-02-17 | $17.52M derived: sum of 4 quarters · filed 2026-02-17 |
| 2024-03-31 | $4.06M 10-Q · filed 2025-05-06 | $7.93M derived: sum of 2 quarters · filed 2026-02-17 | $12.13M derived: sum of 3 quarters · filed 2026-02-17 | $14.87M derived: sum of 4 quarters · filed 2026-02-17 |
| 2023-12-31 | $3.87M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-17 | $8.07M derived: sum of 2 quarters · filed 2026-02-17 | $10.81M derived: sum of 3 quarters · filed 2026-02-17 | $13.08M 10-K · filed 2026-02-17 |
| 2023-09-30 | $4.20M 10-Q · filed 2024-11-12 | $6.94M derived: sum of 2 quarters · filed 2024-11-12 | $9.21M 10-Q · filed 2024-11-12 | $11.32M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $2.74M 10-Q · filed 2024-08-06 | $5.01M 10-Q · filed 2024-08-06 | $7.12M derived: sum of 3 quarters · filed 2025-02-25 | $8.62M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $2.27M 10-Q · filed 2024-05-07 | $4.38M derived: sum of 2 quarters · filed 2025-02-25 | $5.88M derived: sum of 3 quarters · filed 2025-02-25 | $6.15M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $2.11M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $3.61M derived: sum of 2 quarters · filed 2025-02-25 | $3.88M derived: sum of 3 quarters · filed 2025-02-25 | $3.99M 10-K · filed 2025-02-25 |
| 2022-09-30 | $1.50M 10-Q · filed 2023-11-07 | $1.77M derived: sum of 2 quarters · filed 2023-11-07 | $1.88M 10-Q · filed 2023-11-07 | $1.99M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | $272.00K 10-Q · filed 2023-08-08 | $379.00K 10-Q · filed 2023-08-08 | $486.00K derived: sum of 3 quarters · filed 2024-02-26 | $601.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | $107.00K 10-Q · filed 2023-05-09 | $214.00K derived: sum of 2 quarters · filed 2024-02-26 | $329.00K derived: sum of 3 quarters · filed 2024-02-26 | $449.00K derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $222.00K derived: sum of 2 quarters · filed 2024-02-26 | $342.00K derived: sum of 3 quarters · filed 2024-02-26 | $467.00K 10-K · filed 2024-02-26 |
| 2021-09-30 | $115.00K 10-Q · filed 2022-11-14 | $235.00K derived: sum of 2 quarters · filed 2022-11-14 | $360.00K 10-Q · filed 2022-11-14 | $431.00K derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $120.00K 10-Q · filed 2022-08-09 | $245.00K 10-Q · filed 2022-08-09 | $316.00K derived: sum of 3 quarters · filed 2022-08-09 | $339.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $125.00K 10-Q · filed 2022-05-10 | $196.00K derived: sum of 2 quarters · filed 2022-05-10 | $219.00K derived: sum of 3 quarters · filed 2022-05-10 | $222.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $71.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $94.00K derived: sum of 2 quarters · filed 2022-03-15 | $97.00K derived: sum of 3 quarters · filed 2022-03-15 | $144.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $23.00K 10-Q · filed 2021-11-10 | $26.00K derived: sum of 2 quarters · filed 2021-11-10 | $73.00K 10-Q · filed 2021-11-10 | $134.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $3.00K 10-Q · filed 2021-08-16 | $50.00K 10-Q · filed 2021-08-16 | $111.00K derived: sum of 3 quarters · filed 2021-08-16 | $142.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $47.00K 10-Q · filed 2021-05-12 | $108.00K derived: sum of 2 quarters · filed 2021-05-12 | $139.00K derived: sum of 3 quarters · filed 2021-05-12 | $164.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | $92.00K derived: sum of 2 quarters · filed 2021-03-16 | $117.00K derived: sum of 3 quarters · filed 2021-03-16 | $267.00K 10-K · filed 2021-03-16 |
| 2019-09-30 | $31.00K 10-Q · filed 2020-11-09 | $56.00K derived: sum of 2 quarters · filed 2020-11-09 | $206.00K 10-Q · filed 2020-11-09 | $614.00K derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $25.00K 10-Q · filed 2020-08-11 | $175.00K 10-Q · filed 2020-08-11 | $583.00K derived: sum of 3 quarters · filed 2020-08-11 | $988.00K derived: sum of 4 quarters · filed 2020-08-11 |
| 2019-03-31 | $150.00K 10-Q · filed 2020-05-11 | $558.00K derived: sum of 2 quarters · filed 2020-05-11 | $963.00K derived: sum of 3 quarters · filed 2020-05-11 | $1.22M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $408.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $813.00K derived: sum of 2 quarters · filed 2020-03-26 | $1.07M derived: sum of 3 quarters · filed 2020-03-26 | $1.15M 10-K · filed 2020-03-26 |
| 2018-09-30 | $405.00K 10-Q · filed 2019-11-12 | $664.00K derived: sum of 2 quarters · filed 2019-11-12 | $745.00K 10-Q · filed 2019-11-12 | $844.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $259.00K 10-Q · filed 2019-08-12 | $340.00K 10-Q · filed 2019-08-12 | $439.00K derived: sum of 3 quarters · filed 2019-08-12 | $539.00K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $81.00K 10-Q · filed 2019-05-13 | $180.00K derived: sum of 2 quarters · filed 2019-05-13 | $280.00K derived: sum of 3 quarters · filed 2019-05-13 | $377.00K derived: sum of 4 quarters · filed 2019-05-13 |
| 2017-12-31 | $99.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $199.00K derived: sum of 2 quarters · filed 2019-03-28 | $296.00K derived: sum of 3 quarters · filed 2019-03-28 | $386.00K 10-K · filed 2019-03-28 |
| 2017-09-30 | $100.00K 10-Q · filed 2018-11-13 | $197.00K derived: sum of 2 quarters · filed 2018-11-13 | $287.00K 10-Q · filed 2018-11-13 | |
| 2017-06-30 | $97.00K 10-Q · filed 2018-08-13 | $187.00K 10-Q · filed 2018-08-13 | ||
| 2017-03-31 | $90.00K 10-Q · filed 2018-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |